Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Operating Profit

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Operating Profit (Excl OI) ₹30 Cr₹20 Cr₹20 Cr₹1,655,282 Cr₹17 Cr

What is the latest Operating Profit of SYNCOM FORMULATIONS (INDIA) ?

The latest Operating Profit ratio of SYNCOM FORMULATIONS (INDIA) is ₹30 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹30 Cr
Mar2024₹20 Cr
Mar2023₹20 Cr
Mar2022₹1,655,282 Cr
Mar2017₹17 Cr

How is Operating Profit of SYNCOM FORMULATIONS (INDIA) Trending?

Years Operating Profit % Change
Mar2025 ₹30 Cr
48.98
Mar2024 ₹20 Cr
-0.67
Mar2023 ₹20 Cr
-100.00
Mar2022 ₹1,655,282 Cr
9,930,201.10
Mar2017 ₹17 Cr -

Compare Operating Profit of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,420.3 Cr -3.3% -6.2% -30.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,068.0 Cr -0.2% 7.1% 1.1% Stock Analytics
DIVIS LABORATORIES ₹171,847.0 Cr 0.8% -6% 4.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,985.0 Cr 1.2% 6.4% 13.1% Stock Analytics
CIPLA ₹122,826.0 Cr -0.2% 1.4% -0.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,418.0 Cr 1.2% 5.8% 4.2% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-3.3%

-6.2%

-30.6%

SENSEX

0%

2.7%

6.8%


You may also like the below Video Courses